Open AccessCoadministration of Esomeprazole With Fosamprenavir Has No Impact on Steady-State Plasma Amprenavir Pharmacokinetics
Author(s) -
Mark J. Shelton,
Susan L. Ford,
Julie Borland,
Yu Lou,
Mary Beth Wire,
Sherene Min,
Zhengyu Xue,
Geoffrey J. Yuen
Publication year - 2006
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/01.qai.0000219770.97303.43
Subject(s) - amprenavir , pharmacokinetics , pharmacology , ritonavir , medicine , chemistry , viral load , virology , human immunodeficiency virus (hiv) , enzyme , biochemistry , hiv 1 protease , antiretroviral therapy , protease
To evaluate the drug interaction between fosamprenavir (FPV) and esomeprazole (ESO) after repeated doses in healthy adults.